[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.193.74. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
June 14, 2000

HAART Stopping News: Experts Examine Structured Therapy Interruption for HIV

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;283(22):2917-2918. doi:10.1001/jama.283.22.2917

Charlottesville, Va—In the last few years, the success of highly active antiretroviral therapy (HAART) in suppressing HIV viral load levels has given people infected with HIV hope for survival. Yet while the potent multidrug regimens can prolong life for patients, they have many drawbacks. High costs, adverse effects, toxicity, and a complicated medication schedule often cause noncompliance with or abandonment of treatment. Evidence indicates that HAART cannot completely eliminate HIV from the body, as was once hoped.

First Page Preview View Large
First page PDF preview
First page PDF preview
×